VOGLIOS GM 0.2

VOGLIOS GM 0.2 is a triple-action anti-diabetic formulation containing Voglibose 0.2 mg, Glimepiride 2 mg, and Metformin 500 mg (Sustained Release). It is designed to provide comprehensive blood sugar control in patients with Type 2 Diabetes Mellitus, targeting fasting, post-prandial, and overall glucose levels.

Key Benefits

• Controls fasting and post-meal blood sugar levels
• Provides sustained glucose control throughout the day
• Enhances insulin secretion and sensitivity
• Reduces sudden glucose fluctuations
•  Suitable for patients requiring triple oral therapy